---
title: "\"Performance\" Chongqing M&E's annual net profit of RMB 764 million increased by 76.9%, final dividend of 5.5 cents"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280045580.md"
description: "Chongqing M&E announced its 2025 annual performance, with operating revenue of 10.044 billion RMB, an increase of 11.9% year-on-year. The net profit attributable to shareholders is 764 million RMB, a growth of 76.9%, with earnings per share of 0.21 RMB. The final dividend is 0.055 RMB"
datetime: "2026-03-22T08:02:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280045580.md)
  - [en](https://longbridge.com/en/news/280045580.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280045580.md)
---

# "Performance" Chongqing M&E's annual net profit of RMB 764 million increased by 76.9%, final dividend of 5.5 cents

CHONGQING M&E (02722.HK) announced its 2025 annual performance, with operating revenue of 10.044 billion RMB, an increase of 11.9% year-on-year. The net profit attributable to shareholders is 764 million RMB, a growth of 76.9%, with earnings per share of 0.21 RMB. The final dividend is 0.055 RMB

### Related Stocks

- [02722.HK](https://longbridge.com/en/quote/02722.HK.md)
- [588850.CN](https://longbridge.com/en/quote/588850.CN.md)
- [159667.CN](https://longbridge.com/en/quote/159667.CN.md)
- [516960.CN](https://longbridge.com/en/quote/516960.CN.md)

## Related News & Research

- [07:34 ETSANY Heavy Industry veröffentlicht Nachhaltigkeitsbericht 2025](https://longbridge.com/en/news/286557656.md)
- [Precision Tsugami (China) Flags Forthcoming Results From Japanese Parent](https://longbridge.com/en/news/286194451.md)
- [ZAWYA: Joramco rewards employees with up to 12 weeks’ bonus](https://longbridge.com/en/news/287035395.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Assessing BlueNord (OB:BNOR) Valuation After Its US$400 Million Refinancing Deal](https://longbridge.com/en/news/287098111.md)